For the second straight year, PNNL researchers are featured in a special edition of the Journal of Information Warfare. This issue explores the topic of macro cyber resiliency.
PNNL has published a cybersecurity guidance report for marine renewable energy devices to prepare the blue economy for harnessing ocean power from waves, tides, and currents.
One year ago, Verizon announced a partnership that made PNNL the U.S. Department of Energy’s first national laboratory with Verizon 5G ultra-wideband wireless technology.
PNNL highlights four researchers whose joint appointments are creating new and diverse opportunities for expanding knowledge and scientific impact across institutions.
Sentry-SECURE is a new communication and response platform developed by PNNL, VPI, and Microsoft Azure that rapidly and securely transfers radiological alarm data through the cloud.
PNNL teamed with academia and industry to develop a novel zero-emission methane pyrolysis process that produces both hydrogen and high-value carbon solids suitable for an array of manufacturing applications.
As he prepares to enter PNNL's Energy Sciences Center later this year, Vijayakumar 'Vijay' Murugesan is among DOE leaders exploring solutions to design and build transformative materials for batteries of the future.
New 140,000-square-foot facility will advance fundamental chemistry and materials science for higher-performing, cost-effective catalysts and batteries, and other energy efficiency technologies.
PNNL formulated a new type of dual-ion cell chemistry that uses a zinc anode and a natural graphite cathode in an aqueous—or “water-in-bisalt”—electrolyte.
Through two U.S. Department of Energy funding calls awarded in 2020, PNNL is partnering with industry and academia to advance battery materials and processes.
PNNL has published a report that sets the foundation for modeling gaps and technical challenges in optimizing hydropower operations for both energy production and water management.
PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.